|
Federal Register Search Results
CDER - April 2005
Federal Register, Volume 70 (2005)
4/1/05
Total Hits: 1
-
[1] fr01ap05N International Conference
on Harmonisation; Guidance on E2E- Size: 7578 , Score: 212 , HTML
4/4/05
Total Hits: 2
-
[1] fr04ap05N Draft Guidance
for Industry on Clinical Trial Endpoints for the- Size: 6173 , Score: 244 , HTML
-
[2] fr04ap05R Use of Ozone-Depleting
Substances; Removal of Essential-Use- Size: 192259 , Score: 108 , HTML
4/5/05
Total Hits: 0
4/6/05
Total Hits: 0
4/7/05
Total Hits: 0
4/8/05
Total Hits: 0
4/11/05
Total Hits: 3
-
[1] fr11ap05N Advisory Committee
for Pharmaceutical Science; Notice of Meeting- Size: 3763 , Score: 148 , HTML
-
[2] fr11ap05N Antiviral Drugs
Advisory Committee; Notice of Meeting- Size: 3335 , Score: 121 , HTML
-
[3] fr11ap05N Oncologic Drugs
Advisory Committee; Notice of Meeting- Size: 3421 , Score: 120 , HTML
4/12/05
Total Hits: 0
4/13/05
Total Hits: 1
-
[1] fr13ap05N Request for Nominations
for Voting Consumer Representative- Size: 7274 , Score: 108 , HTML
4/14/05
Total Hits: 3
-
[1] fr14ap05N Draft Guidance
for Industry on Exploratory Investigational New- Size: 8276 , Score: 154 , HTML
-
[2] fr14ap05N Drugs for Human
Use; Drug Efficacy Study Implementation;- Size: 6580 , Score: 135 , HTML
-
[3] fr14ap05N Drug Safety and
Risk Management Advisory Committee; Notice of- Size: 4234 , Score: 115 , HTML
4/15/05
Total Hits: 0
4/18/05
Total Hits: 1
-
[1] fr18ap05N Draft Guidance for Industry on User
Fee Waivers for Fixed Dose
- Size: 7105 , Score: 639
, HTML
4/19/05
Total Hits: 0
4/20/05
Total Hits: 1
-
[1] fr20ap05N Levothyroxine Sodium Therapeutic Equivalence;
Public Meeting
- Size: 7817 , Score: 635
, HTML
4/21/05
Total Hits: 1
-
[1] fr21ap05N Guidance for Industry on Providing Regulatory
Submissions in
- Size: 9740 , Score: 804
, HTML
4/22/05
Total Hits: 1
-
[1] fr22ap05N Hospira, Inc. et al.; Withdrawal of
Approval of 76 New Drug
- Size: 1848 , Score: 528
, HTML
4/25/05
Total Hits: 0
4/26/05
Total Hits: 0
4/27/05
Total Hits: 1
-
[1] fr27ap05N Cellular, Tissue and Gene Therapies
Advisory Committee (Formerly
- Size: 3859 , Score: 471
, HTML
4/28/05
Total Hits: 2
-
[1] fr28ap05N Guidance for Reviewers on Evaluating
the Risks of Drug Exposure
- Size: 7452 , Score: 847
, HTML
- [2] fr28ap05N High Chemical Co. et al.; Proposal to
Withdraw Approval of 13 New
- Size: 10383 , Score: 521
, HTML
4/29/05
Total Hits: 1
-
[1] fr29ap05N Determination of Regulatory Review Period
for Purposes of Patent
- Size: 6648 , Score: 537
, HTML
© 1997-2006 Betterchem
Corp.
|